Dr. Little is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 N 12th St
Suite 500
Phoenix, AZ 85006Phone+1 602-839-2606Fax+1 602-239-4233
Education & Training
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1995 - 1999
- Federal University of Bahia Faculty of MedicineClass of 1984
Certifications & Licensure
- AZ State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Publications & Presentations
PubMed
- 97 citationsIncreasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Follo...Thomas G. Cotter, Sonali Paul, Burhaneddin Sandikci, Thomas Couri, Adam S. Bodzin
Hepatology. 2019-06-01 - 151 citationsInternational Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.Michael Charlton, Josh Levitsky, Bashar Aqel, John O'Grady, Julie Hemibach
Transplantation. 2018-05-01 - 63 citationsImproved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.Thomas G. Cotter, Sonali Paul, Burhaneddin Sandikci, Thomas Couri, Adam S. Bodzin
Liver Transplantation. 2019-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: